Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,212
Total Claims
$909K
Drug Cost
517
Beneficiaries
$1,759
Cost/Patient
Risk Score Breakdown 18/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+8%
Opioid rate vs peers
2.8% vs 2.6% avg
+65%
Cost per patient vs peers
$1,759 vs $1,068 avg
+56%
Brand preference vs peers
14.0% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
2.8%
Opioid Rate
313
Opioid Claims
$7,836
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,553 claims · $758K
Generic: 9,526 claims · $144K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 81 | $88K |
| Semaglutide | 69 | $83K |
| Fluticasone/Umeclidin/Vilanter | 83 | $79K |
| Empagliflozin | 42 | $37K |
| Insulin Glargine,hum.Rec.Anlog | 51 | $31K |
| Linaclotide | 33 | $24K |
| Budesonide/Formoterol Fumarate | 53 | $23K |
| Dulaglutide | 14 | $22K |
| Tirzepatide | 20 | $22K |
| Empagliflozin/Metformin Hcl | 26 | $22K |
| Rivaroxaban | 30 | $20K |
| Dapagliflozin Propanediol | 11 | $18K |
| Tiotropium Bromide | 22 | $17K |
| Mirabegron | 25 | $15K |
| Vortioxetine Hydrobromide | 18 | $14K |
Prescribing Profile
Patient Profile
72
Avg Age
58%
Female
1.12
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About